Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population

Tumor Biology

Volumn 36, Issue 6, 2015, Pages 4575-4582

  He, Bangshun ^a   Pan, Yuqin ^a   Xu, Yeqiong ^b   Deng, Qiwen ^a   Sun, Huling ^c   Gao, Tianyi ^a   Wang, Shukui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Changshu Medicine Examination Institute   (China)

^c NANJING NORMAL UNIVERSITY   (China)

Author keywords

Breast cancer; MicroRNA; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR; MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A2; MICRORNA 27A; MICRORNA 423; MICRORNA 499; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER TISSUE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOSITY; HSA MIR499 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE; MAJOR CLINICAL STUDY; MENOPAUSE; MIRNA GENE; MIRNA146A GENE; MIRNA149 GENE; MIRNA196A2 GENE; MIRNA27A GENE; MIRNA423 GENE; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; MIDDLE AGED; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 84938995958     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3102-2     Document Type: Article

References (33)

1. Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol. 2008;66:65–74.
2. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell. 1993;75:843–54.
3. Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
4. Esquela-Kerscher A, Slack FJ. Oncomirs—micrornas with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
5. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microrna-1 and microrna-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38:228–33.
6. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microrna that controls cell proliferation and regulates the proapoptotic gene hid in drosophila. Cell. 2003;113:25–36.
7. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. Mir-15 and mir-16 induce apoptosis by targeting bcl2. Proc Natl Acad Sci U S A. 2005;102:13944–9.
8. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microrna pathway. Nature. 2005;435:974–8.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.
10. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753–6.
11. Iwai N, Naraba H. Polymorphisms in human pre-mirnas. Biochem Biophys Res Commun. 2005;331:1439–44.
12. Ryan BM, Robles AI, Harris CC. Genetic variation in microrna networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389–402.
13. He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, et al. The association between four genetic variants in micrornas (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 2012;7:e49032.
14. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, et al. Evaluation of snps in mir-146a, mir196a2 and mir-499 as low-penetrance alleles in german and italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.
15. Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet. 2011;14:417–21.
16. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, et al. Common genetic variants in pre-micrornas were associated with increased risk of breast cancer in chinese women. Hum Mutat. 2009;30:79–84.
17. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, et al. Microrna mir-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.
18. Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu H, et al. Associations of mirna polymorphisms and female physiological characteristics with breast cancer risk in chinese population. Eur J Cancer Care (Engl). 2012;21:274–80.
19. Gabriel S, Ziaugra L, Tabbaa D. Snp genotyping using the sequenom massarray iplex platform. Curr Protoc Hum Genet 2009;Chapter 2:Unit 2 12.
20. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.
21. Gul AE, Keser SH, Barisik NO, Kandemir NO, Cakir C, Sensu S, et al. The relationship of cerb b 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas. Diagn Pathol. 2010;5:13.
22. Ma XP, Zhang T, Peng B, Yu L, de Jiang K. Association between microrna polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One. 2013;8:e79584.
23. Srivastava K, Srivastava A. Comprehensive review of genetic association studies and meta-analyses on mirna polymorphisms and cancer risk. PLoS One. 2012;7:e50966.
24. Chen QH, Wang QB, Zhang B. Ethnicity modifies the association between functional microrna polymorphisms and breast cancer risk: a huge meta-analysis. Tumour Biol. 2014;35:529–43.
25. Xu Y, Gu L, Pan Y, Li R, Gao T, Song G, et al. Different effects of three polymorphisms in micrornas on cancer risk in asian population: evidence from published literatures. PLoS One. 2013;8:e65123.
26. Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J, et al. There is no association between microrna gene polymorphisms and risk of triple negative breast cancer in a chinese han population. PLoS One. 2013;8:e60195.
27. Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alsaif MA, et al. Differential expression profile and genetic variants of micrornas sequences in breast cancer patients. PLoS One. 2012;7:e30049.
28. Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an iranian population. Biomark Med. 2014;8:259–67.
29. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microrna expression atlas based on small rna library sequencing. Cell. 2007;129:1401–14.
30. Wang AX, Xu B, Tong N, Chen SQ, Yang Y, Zhang XW, et al. Meta-analysis confirms that a common g/c variant in the pre-mir-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet Mol Res. 2012;11:3051–62.
31. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the mir-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.
32. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common snp in pre-mir-146a decreases mature mir expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.
33. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microrna-146 suppresses nf-kappab activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27:5643–7.